{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:01:50Z","timestamp":1776142910406,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_143867"],"award-info":[{"award-number":["320030_143867"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ID Suisse AG","award":["n.a."],"award-info":[{"award-number":["n.a."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00228-016-2043-z","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T23:24:59Z","timestamp":1459207499000},"page":"859-867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation"],"prefix":"10.1007","volume":"72","author":[{"given":"David","family":"Niedrig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Maechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesa","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascia","family":"Corti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kovari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Russmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"issue":"1","key":"2043_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1755-5922.12054","volume":"32","author":"E Abo-Salem","year":"2014","unstructured":"Abo-Salem E, Fowler JC, Attari M, Cox CD, Perez-Verdia A, Panikkath R, Nugent K (2014) Antibiotic-induced cardiac arrhythmias. Cardiovasc Ther 32(1):19\u201325. doi: 10.1111\/1755-5922.12054","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"2043_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000334441","volume":"120","author":"A Briasoulis","year":"2011","unstructured":"Briasoulis A, Agarwal V, Pierce WJ (2011) QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications. Cardiology 120(2):103\u2013110. doi: 10.1159\/000334441","journal-title":"Cardiology"},{"issue":"6","key":"2043_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/pds.1607","volume":"17","author":"C Astrom-Lilja","year":"2008","unstructured":"Astrom-Lilja C, Odeberg JM, Ekman E, Hagg S (2008) Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf 17(6):587\u2013592. doi: 10.1002\/pds.1607","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"20","key":"2043_CR4","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM (2012) Azithromycin and the risk of cardiovascular death. N Engl J Med 366(20):1881\u20131890. doi: 10.1056\/NEJMoa1003833","journal-title":"N Engl J Med"},{"issue":"12","key":"2043_CR5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1592\/phco.21.20.1468.34482","volume":"21","author":"R Frothingham","year":"2001","unstructured":"Frothingham R (2001) Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin. Pharmacotherapy 21(12):1468\u20131472","journal-title":"Pharmacotherapy"},{"key":"2043_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.259","author":"RL Woosley","year":"2015","unstructured":"Woosley RL, Whyte J, Mohamadi A, Romero K (2015) Medical decision support systems and therapeutics: the role of autopilots. Clin Pharmacol Ther. doi: 10.1002\/cpt.259","journal-title":"Clin Pharmacol Ther"},{"key":"2043_CR7","unstructured":"Swissmedic (2015) Swiss Agency for Therapeutic Products: http:\/\/www.swissmedicinfo.ch - Product information."},{"issue":"1","key":"2043_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1476-5381.2011.01367.x","volume":"164","author":"A Varro","year":"2011","unstructured":"Varro A, Baczko I (2011) Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. Br J Pharmacol 164(1):14\u201336. doi: 10.1111\/j.1476-5381.2011.01367.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2043_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijcard.2010.10.126","volume":"149","author":"S Patane","year":"2011","unstructured":"Patane S (2011) Torsade de pointes, QT interval prolongation and renal disease. Int J Cardiol 149(2):241\u2013242. doi: 10.1016\/j.ijcard.2010.10.126","journal-title":"Int J Cardiol"},{"issue":"2","key":"2043_CR10","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.ijcard.2007.11.070","volume":"130","author":"S Patane","year":"2008","unstructured":"Patane S, Marte F, Di Bella G, Curro A, Coglitore S (2008) QT interval prolongation, torsade de pointes and renal disease. Int J Cardiol 130(2):e71\u2013e73. doi: 10.1016\/j.ijcard.2007.11.070","journal-title":"Int J Cardiol"},{"issue":"1","key":"2043_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1523-1755.2005.00072.x","volume":"67","author":"GA Stewart","year":"2005","unstructured":"Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG (2005) Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 67(1):217\u2013226. doi: 10.1111\/j.1523-1755.2005.00072.x","journal-title":"Kidney Int"},{"issue":"9","key":"2043_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jacc.2010.01.001","volume":"55","author":"BJ Drew","year":"2010","unstructured":"Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W, American Heart Association Acute Cardiac Care Committee of the Council on Clinical C, Council on Cardiovascular N, American College of Cardiology Foundation (2010) Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College Of Cardiology Foundation. J Am Coll Cardiol 55(9):934\u2013947. doi: 10.1016\/j.jacc.2010.01.001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2043_CR13","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.CIR.84.4.1516","volume":"84","author":"EG Schouten","year":"1991","unstructured":"Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J (1991) QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84(4):1516\u20131523","journal-title":"Circulation"},{"issue":"2","key":"2043_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/CCM.0b013e318232db4a","volume":"40","author":"D Pickham","year":"2012","unstructured":"Pickham D, Helfenbein E, Shinn JA, Chan G, Funk M, Weinacker A, Liu JN, Drew BJ (2012) High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in practice (QTIP) study. Crit Care Med 40(2):394\u2013399. doi: 10.1097\/CCM.0b013e318232db4a","journal-title":"Crit Care Med"},{"issue":"5","key":"2043_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/amiajnl-2011-000612","volume":"19","author":"S Phansalkar","year":"2012","unstructured":"Phansalkar S, Desai AA, Bell D, Yoshida E, Doole J, Czochanski M, Middleton B, Bates DW (2012) High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc 19(5):735\u2013743. doi: 10.1136\/amiajnl-2011-000612","journal-title":"J Am Med Inform Assoc"},{"issue":"7","key":"2043_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/imj.12473","volume":"44","author":"JH Martin","year":"2014","unstructured":"Martin JH, Coombes I (2014) Mortality from common drug interactions systems, knowledge and clinical reasoning to optimise prescribing. Intern Med J 44(7):621\u2013624. doi: 10.1111\/imj.12473","journal-title":"Intern Med J"},{"issue":"6","key":"2043_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","volume":"80","author":"PJ Neuvonen","year":"2006","unstructured":"Neuvonen PJ, Niemi M, Backman JT (2006) Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 80(6):565\u2013581. doi: 10.1016\/j.clpt.2006.09.003","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"2043_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.amjcard.2004.07.080","volume":"94","author":"TA Jacobson","year":"2004","unstructured":"Jacobson TA (2004) Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Am J Cardiol 94(9):1140\u20131146. doi: 10.1016\/j.amjcard.2004.07.080","journal-title":"Am J Cardiol"},{"issue":"12","key":"2043_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","volume":"158","author":"AM Patel","year":"2013","unstructured":"Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX (2013) Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med 158(12):869\u2013876. doi: 10.7326\/0003-4819-158-12-201306180-00004","journal-title":"Ann Intern Med"},{"issue":"6","key":"2043_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.clpt.2004.08.018","volume":"76","author":"MT Granfors","year":"2004","unstructured":"Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ (2004) Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1\u00a0A2-mediated presystemic metabolism. Clin Pharmacol Ther 76(6):598\u2013606. doi: 10.1016\/j.clpt.2004.08.018","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2043_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/YIC.0000000000000103","volume":"31","author":"DF Niedrig","year":"2016","unstructured":"Niedrig DF, Gott C, Fischer A, Muller ST, Greil W, Bucklar G, Russmann S (2016) Second-generation antipsychotics in a tertiary care hospital: prescribing patterns, metabolic profiles, and drug interactions. Int Clin Psychopharmacol 31(1):42\u201350. doi: 10.1097\/YIC.0000000000000103","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"2043_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00002018-200932020-00008","volume":"32","author":"A Zambon","year":"2009","unstructured":"Zambon A, Polo Friz H, Contiero P, Corrao G (2009) Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs. Drug Saf 32(2):159\u2013167. doi: 10.2165\/00002018-200932020-00008","journal-title":"Drug Saf"},{"issue":"20","key":"2043_CR23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","volume":"66","author":"YJ Cheng","year":"2015","unstructured":"Cheng YJ, Nie XY, Chen XM, Lin XX, Tang K, Zeng WT, Mei WY, Liu LJ, Long M, Yao FJ, Liu J, Liao XX, Du ZM, Dong YG, Ma H, Xiao HP, Wu SH (2015) The role of macrolide antibiotics in increasing cardiovascular risk. J Am Coll Cardiol 66(20):2173\u20132184. doi: 10.1016\/j.jacc.2015.09.029","journal-title":"J Am Coll Cardiol"},{"key":"2043_CR24","unstructured":"https:\/\/crediblemeds.org\/index.php\/login\/dlcheck (2015) CredibleMeds. QTDrugs Lists"},{"key":"2043_CR25","unstructured":"http:\/\/www.mediq.ch (2014) mediQ - Qualit\u00e4tszentrum f\u00fcr Medikamentensicherheit. Psychiatrische Dienste Aargau AG."},{"issue":"9","key":"2043_CR26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"11","key":"2043_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2008.12.014","volume":"53","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, Gorgels A, Hancock EW, Josephson M, Kligfield P, Kors JA, Macfarlane P, Mason JW, Mirvis DM, Okin P, Pahlm O, van Herpen G, Wagner GS, Wellens H, Arrhythmias Committee CCC, Heart Rhythm S, American Heart Association Electrocardiography, American College of Cardiology Foundation (2009) AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography And Arrhythmias Committee, council on clinical cardiology; the American College Of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society For Computerized Electrocardiology. J Am Coll Cardiol 53(11):982\u2013991. doi: 10.1016\/j.jacc.2008.12.014","journal-title":"J Am Coll Cardiol"},{"key":"2043_CR28","unstructured":"WHO Uppsala Monitoring Center (2015) The use of the WHO-UMC system for standardised case causality assessment - http:\/\/who-umc.org\/Graphics\/24734.pdf ."},{"issue":"3","key":"2043_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2143\/AC.67.3.2160727","volume":"67","author":"B Haring","year":"2012","unstructured":"Haring B, Bauer W (2012) Ciprofloxacin and the risk for cardiac arrhythmias: culprit delicti or watching bystander? Acta Cardiol 67(3):351\u2013354. doi: 10.2143\/AC.67.3.2160727","journal-title":"Acta Cardiol"},{"issue":"1","key":"2043_CR30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.59.1.122","volume":"59","author":"J Kang","year":"2001","unstructured":"Kang J, Wang L, Chen XL, Triggle DJ, Rampe D (2001) Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol Pharmacol 59(1):122\u2013126","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2043_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/01.md.0000085057.63483.9b","volume":"82","author":"D Zeltser","year":"2003","unstructured":"Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S (2003) Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 82(4):282\u2013290. doi: 10.1097\/01.md.0000085057.63483.9b","journal-title":"Medicine (Baltimore)"},{"key":"2043_CR32","unstructured":"Rote Liste Service GmbH (2015) SPC Clarithromycin - http:\/\/www.fachinfo.de ."},{"issue":"4","key":"2043_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.mayocp.2013.01.013","volume":"88","author":"KH Haugaa","year":"2013","unstructured":"Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ (2013) Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc 88(4):315\u2013325. doi: 10.1016\/j.mayocp.2013.01.013","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2043_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCOUTCOMES.113.000651","volume":"7","author":"JE Tisdale","year":"2014","unstructured":"Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ (2014) Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 7(3):381\u2013390. doi: 10.1161\/CIRCOUTCOMES.113.000651","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"e1","key":"2043_CR35","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1136\/amiajnl-2014-002896","volume":"22","author":"A Sorita","year":"2015","unstructured":"Sorita A, Bos JM, Morlan BW, Tarrell RF, Ackerman MJ, Caraballo PJ (2015) Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes. J Am Med Inform Assoc 22(e1):e21\u2013e27. doi: 10.1136\/amiajnl-2014-002896","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"2043_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","volume":"6","author":"JE Tisdale","year":"2013","unstructured":"Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, Kovacs RJ (2013) Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 6(4):479\u2013487. doi: 10.1161\/CIRCOUTCOMES.113.000152","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"2043_CR37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/jcph.322","volume":"54","author":"P Zuo","year":"2014","unstructured":"Zuo P, Haberer LJ, Fang L, Hunt TL, Ridgway D, Russo MW (2014) Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double-blind, placebo-, and active-controlled thorough QT study. J Clin Pharmacol 54(11):1221\u20131229. doi: 10.1002\/jcph.322","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"2043_CR38","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s40264-015-0338-0","volume":"38","author":"A Arana","year":"2015","unstructured":"Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ (2015) Risk of Out-Of-Hospital sudden cardiac death in users of domperidone, Proton pump inhibitors, or metoclopramide: a population-based nested case-control study. Drug Saf 38(12):1187\u20131199. doi: 10.1007\/s40264-015-0338-0","journal-title":"Drug Saf"},{"issue":"6","key":"2043_CR39","doi-asserted-by":"publisher","first-page":"e0127213","DOI":"10.1371\/journal.pone.0127213","volume":"10","author":"A Poncet","year":"2015","unstructured":"Poncet A, Gencer B, Blondon M, Gex-Fabry M, Combescure C, Shah D, Schwartz PJ, Besson M, Girardin FR (2015) Electrocardiographic screening for prolonged QT interval to reduce sudden cardiac death in psychiatric patients: a cost-effectiveness analysis. PLoS one 10(6):e0127213. doi: 10.1371\/journal.pone.0127213","journal-title":"PLoS one"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2043-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2043-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2043-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T21:46:41Z","timestamp":1567720001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2043-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2043-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}